Search

everythinglearnresearchcommunity

for

Search:↓

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Removing Lrig1-positive stem cells in mice causes temporary loss of sebaceous glands.

Electrical epilation damages hair follicles and surrounding skin, likely preventing hair regrowth.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Modern hair restoration techniques can effectively treat hair loss and provide natural-looking results.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

The document reviews key historical figures and discoveries in dermatology.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Treatments for hair loss vary, but cell-based options may be the future.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Spironolactone treatment increases the amount of testosterone available in the body.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.